ArticleCancer research and treatment2023

Combination of the LARS1 Inhibitor, BC-LI-0186 with a MEK1/2 Inhibitor Enhances the Anti-Tumor Effect in Non-Small Cell Lung Cancer.

Sang Hoon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.